Indivior PLC (INDV)

1,955.00 -7.00 (-0.36%)
Close GBP Disclaimer

Indivior PLC Company Profile

Equity Type
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. It focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its SUBLOCADE, SUBUTEX and SUBOXONE are used for the treatment of opioid use disorder (OUD). Its PERSERIS is used for the treatment of Schizophrenia. Its pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet, and Buprenorphine Sublingual Tablet. Its portfolio of products is available in over 40 countries.
Contact Information
North Chesterfield,23235 United States
804 379 1090
Top Executives
Joanna Susan Le Couilliard 58 2021 Independent Non-Executive Director
Mark Crossley 0 2014 CEO & Executive Director
Graham C. Hetherington 62 2019 Independent Non-Executive Chairman
Juliet Thompson 55 2021 Independent Non-Executive Director
Jerome J. Lande 45 2021 Non-Executive Director
Daniel J. Phelan 71 2014 Senior Independent Director
Lorna Parker 0 2014 Independent Non-Executive Director
Mark P. Stejbach 58 2021 Independent Non-Executive Director
A. Thomas McLellan 0 2014 Independent Non-Executive Director
Peter James Jonathan Bains 64 2019 Independent Non-Executive Director
Ryan Preblick 0 2020 CFO & Executive Director
Barbara A. Ryan 61 2022 Independent Non-Executive Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles